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Abstract
Yes-associated protein (YAP) is a transcriptional co-factor involved in many cell processes, including development,
proliferation, stemness, differentiation, and tumorigenesis. It has been described as a sensor of mechanical and
biochemical stimuli that enables cells to integrate environmental signals. Although in the liver the correlation between
extracellular matrix elasticity (greatly increased in the most of chronic hepatic diseases), differentiation/functional state
of parenchymal cells and subcellular localization/activation of YAP has been previously reported, its role as regulator of
the hepatocyte differentiation remains to be clarified. The aim of this study was to evaluate the role of YAP in the
regulation of epithelial/hepatocyte differentiation and to clarify how a transducer of general stimuli can integrate
tissue-specific molecular mechanisms determining specific cell outcomes. By means of YAP silencing and
overexpression we demonstrated that YAP has a functional role in the repression of epithelial/hepatocyte
differentiation by inversely modulating the expression of Snail (master regulator of the epithelial-to-mesenchymal
transition and liver stemness) and HNF4α (master regulator of hepatocyte differentiation) at transcriptional level,
through the direct occupancy of their promoters. Furthermore, we found that Snail, in turn, is able to positively control
YAP expression influencing protein level and subcellular localization and that HNF4α stably represses YAP transcription
in differentiated hepatocytes both in cell culture and in adult liver. Overall, our data indicate YAP as a new member of
the HNF4/Snail epistatic molecular circuitry previously demonstrated to control liver cell state. In this model, the
dynamic balance between three main transcriptional regulators, that are able to control reciprocally their expression/
activity, is responsible for the induction/maintenance of different liver cell differentiation states and its modulation
could be the aim of therapeutic protocols for several chronic liver diseases.
Introduction
YAP (Yes-associated protein, Yki ortholog) is a tran-
scriptional co-factor able to regulate a large number of
genes involved in several cell processes, including pro-
liferation, differentiation, organ size control and main-
tenance of stemness traits in embryonic and cancer stem
cells1. YAP is the downstream effector of the Hippo
pathway, an oncosuppressor signaling known to be altered
in various human tumors2. Hippo activity depends on
several extra- and intracellular stimuli and involves the
function of MSTs and LATS1/2 kinases that target YAP
thus causing its cytoplasmic sequestration and protea-
some degradation3–7. Inversely, when Hippo pathway is
inactivated, the un-phosphorylated form of YAP translo-
cates into the nucleus where, in association with tran-
scription factors mainly belonging to the TEAD/TEF
family, activates several genes, some of which with func-
tions yet unclear8.
Regarding cell differentiation, YAP nuclear localization
and its transcriptional activity have been related either to
proliferation and maintenance of stem/progenitor cells or
to activation of specific differentiation programs. In mice,
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YAP overexpression provokes dedifferentiation of intest-
inal cells together with an expansion of stem cell com-
partment9. Similarly, YAP overexpression in skin alters
cell stratification impairing terminal differentiation of
keratinocytes10. On the other hand, an active nuclear YAP
correlates with the differentiation of mesenchymal stem
cells toward osteoblasts11,12 as well as with the astrocyte
differentiation from neural stem cells13. Furthermore, it
has been reported that an increase of YAP level induces
epithelial-to-mesenchymal transition (EMT) mainly
involved in epithelial cancer progression14.
In the adult liver, the activity of Hippo pathway con-
trols liver cell fate, as suggested by studies in murine
models, where its complete inactivation induces hepato-
cyte dedifferentiation15. Moreover, it has been recently
demonstrated that, during mouse liver development,
Hippo signaling controls the shift of gene expression
from hepatoblasts to hepatocytes by influencing the
redistribution of master transcriptional factors on a wide
range of promoters and enhancers16.
On the other hand, the exogenous expression of YAP
induces hepatocyte proliferation and organ hyperplasia
together with subversion of the normal metabolic zona-
tion, acquisition of cholangiocyte markers in hepatocytes,
and expansion of progenitor cell compartment17.
One of the main stimuli inducing Hippo inactivation and
YAP nuclear translocation is the mechanical stress trans-
mitted from extracellular environment to cytoskeleton, by
cell stretching or extracellular matrix (ECM) increased
rigidity18. In the liver, the normal organ stiffness drama-
tically increases during fibrosis, a pathological condition
resulting from chronic injury, including viral and toxic
hurts19. As suggested by studies of hepatocyte functions in
cells cultured on substrates of different elasticity, the
increase of ECM rigidity in vivo, other than to subvert the
liver circulatory dynamics, can directly affect hepatocyte
differentiation and function. We have recently shown that
(i) manipulation of substrate stiffness influences the dif-
ferentiation of liver progenitor cells as well as the func-
tionality of hepatocytes and (ii) YAP subcellular
localization/activity correlates with different differentia-
tion states and functions of liver cells20. However, while
YAP has been well described as an intracellular mechan-
ical rheostat, little work has been done so far to under-
stand how it integrates general extracellular cues into
liver-specific molecular mechanisms and cell outcome.
We previously demonstrated that two master factors,
Snail and HNF4α, play a pivotal role in the metastability of
liver stem/precursor cells, in the maintenance of epithelial/
hepatocyte phenotype and in the dynamic events of EMT
and mesenchymal-to-epithelial transition (MET)21–23.
Snail is a well-characterized transcriptional inhibitor that
acts as a master regulator of the mesenchymal program in
EMT and in liver stemness22,24. Moreover, its expression
in tumor cells correlates with a more aggressive and
metastatic phenotype25–27. HNF4α is a transcriptional
factor able to orchestrate the expression of several epi-
thelial markers in hepatocytes28 as well as to confer to
fibroblasts an epithelial-like morphology29 and to re-
establish a differentiated phenotype in invasive hepato-
cellular carcinoma cells, both in vivo and in vitro30. This
latter ability granted the role of MET master gene to
HNF4α. We previously showed that HNF4α and Snail are
part of a liver-specific mini-circuitry of reciprocal inhibi-
tion whose balance is responsible for different cell out-
comes (i.e., differentiation vs stemness; MET vs EMT;
tumor suppression vs tumor progression)21–23,31. Notably,
we also described a correlation among HNF4α, Snail and
YAP expression levels during dynamic differentiation of
liver stem/progenitor cell lines toward hepatocytes,
obtained in traditional cell culture conditions as well as
culturing cells on low stiffness hydrogel20,22.
Data presented here show a direct role of YAP in the
repression of liver cell differentiation through the oppo-
site regulation of Snail and HNF4α. In particular, gene
expression analysis performed in condition of YAP
silencing and YAP overexpression, together with ChIP
assays exploring the dynamic recruitment of YAP on Snail
and HNF4α gene regulatory regions, showed a direct
involvement of YAP in Snail gene upregulation and
HNF4α gene repression. Interestingly, we also observed
that Snail and HNF4α, in turn, are able to influence YAP
expression/activity in opposite manner. In particular,
HNF4α was shown to be stably recruited on YAP pro-
moter and to repress its expression both in hepatocyte cell
lines and in adult livers.
In conclusion, our data point to YAP as a new leading
player of liver cell differentiation process. It integrates an
epistatic molecular circuitry of liver-specific transcrip-
tional regulation, in which the balance between three
different master regulators controls liver cell state.
Results
YAP nuclear localization and activity inversely correlate
with hepatocyte differentiation in liver cell lines
Our recently published data showed the pivotal role
played by different ECM stiffness in the maintenance of
liver cell stemness and in the induction/maintenance of
hepatocyte differentiation as well as the correlation
between ECM rigidity, specific cell outcome and YAP
localization/activity20.
Moreover, YAP activity has been demonstrated to be
influenced by several other stimuli known to impact on
hepatocyte differentiation, such as hormonal signals acting
through G-protein-coupled and tyrosine kinase recep-
tors32,33, and to play a pivotal role in EMT14, a process
responsible for hepatocyte dedifferentiation in vivo and
in vitro.
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Starting from these observations, we investigated a
possible direct involvement of YAP in the induction and
maintenance of epithelial/hepatocyte differentiation of
liver cells and the molecular mechanisms involved.
In order to verify the correlation between YAP sub-
cellular localization/activity and cell differentiation state,
independently from the substrate stiffness, we analyzed
two liver cell lines, largely characterized in our laboratory,
as models of liver stem/progenitor cells (RLSCs, from
resident liver stem cells) and of functional hepatocytes
(HepE14)34–36. The analysis of hepatocyte-specific tran-
scriptional profile (including HNF4α, albumin, apolipo-
protein-C3, and transthyretin genes), in RLSC and
HepE14 cells showed a strict correlation between hepa-
tocyte differentiation (Fig. 1a) and YAP state (Fig. 1a, b).
In fact, YAP is expressed, properly located in the nucleus
and active on its major positive target gene, connective
tissue growth factor (CTGF)37, in undifferentiated cells.
Conversely, only a low level of transcripts and scarce
protein, mainly localized into the cytoplasm, were
detectable in hepatocytes (Fig. 1a, b).
This result, besides confirming the inverse correlation
between YAP activity and hepatocyte differentiation,
that we previously observed by culturing cells on dif-
ferent ECM stiffness20, also indicated that RLSC and
HepE14 cell lines are suitable cell models to investigate
the role played by YAP in the process of liver cell
differentiation.
YAP has a functional role in the repression of epithelial/
hepatocyte differentiation by regulating the expression of
EMT and MET master genes in opposite manner
Being YAP subcellular localization and activity related
to different liver cell states, we formally proved its role in
hepatocyte differentiation, by means of experiments of
YAP silencing and overexpression performed in
mesenchymal like/undifferentiated RLSC and epithelial/
differentiated HepE14 cell lines, respectively.
In YAP-silenced RLSCs, the expression of the epithelial/
hepatocyte master gene HNF4α, the liver function genes
transthyretin (TTR) and albumin (ALB), and the epithelial
gene occludin (OCLN) resulted upregulated, while the
mesenchymal marker and EMT master gene Snail resul-
ted significantly decreased (Fig. 1c). The inverse mod-
ulation of HNF4α and Snail, the MET and EMT master
genes, respectively, was confirmed at protein level (Fig. 1d).
As expected, YAP silencing induced the upregulation of
DNA-damage-inducible transcript 4 (DDIT4), a negative
YAP-target gene, and the downregulation of cysteine rich
protein 61 (Cyr61), a positive YAP-target gene, both
involved in opposite manner in the regulation of stem-
ness/cancer properties in epithelial cells38,39 (Fig. 1c).
However, YAP silencing resulted insufficient to induce in
RLSCs a fully differentiated phenotype, as demonstrated
by the slight increase of the cell–cell adhesion molecule E-
cadherin and the maintenance of an undifferentiated
morphology (data not shown). Instead, the experimental
neutralization of the residual YAP activity in HepE14 cells
enhanced the epithelial/hepatocyte differentiation, as
assessed by the transcriptional profile and by the massive
increase of HNF4α protein level (Fig. 1e, f). Moreover, a
significant induction of E-cadherin expression and its
localization to the plasma-membrane were observed,
ultimately causing a strengthening of the epithelial phe-
notype (Fig. 1g).
Overall, this data indicates that YAP downregulation
represents a crucial event in the triggering of the differ-
entiation process in progenitor cells and in the accom-
plishment of a full epithelial/hepatocyte program in
cultured hepatocytes.
Coherently with the results obtained in experiments of
silencing, the overexpression in HepE14 cells of a con-
stitutively active mutant of YAP (i.e., resistant to LATS1/
2-dependent inhibitory phosphorylations), named
YAP5SA7, produced a significant transcriptional down-
regulation of HNF4α, E-cadherin, TTR, and albumin
genes (Fig. 2a), together with a massive reduction of
HNF4α protein level (Fig. 2b). In addition, a significant
upregulation of Snail transcripts (Fig. 2a), and protein
(Fig. 2b) can be observed. Snail protein, moreover,
appeared localized in the nucleus (Fig. 2c, left panels),
where most likely was responsible for the transcriptional
downregulation of E-cadherin, its well-known target gene.
The E-cadherin transcriptional inhibition, together with
the delocalization from plasma-membrane of the residual
protein, correlated with an impairment of the epithelial
cell phenotype (Fig. 2c, right panels).
Notably, to increase the significance of these results and
to generalize the observations, experiments of YAP
overexpression have been performed in two additional
functional hepatocyte cell lines, in which a similar mod-
ulation of gene expression has been observed (Supple-
mentary Fig. S1).
Altogether, these findings demonstrated a key role of
YAP in the negative control of epithelial/hepatocyte dif-
ferentiation and suggested the transcriptional control of
the master genes HNF4α and Snail, as one of the major
regulative mechanisms involved.
YAP directly controls Snail and HNF4α transcription
YAP is recruited on target genes by transcription fac-
tors, mainly those belonging to TEAD family40. There-
fore, to investigate whether, in liver cells, YAP regulates
Snail and HNF4α expression at transcriptional level, we
accomplished a preliminary analysis of gene promoters
by Genomatix MatInspector, looking for putative TEAD
binding sites. Concerning HNF4α, previous studies
demonstrated that YAP can be recruited on a TEAD
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Fig. 1 (See legend on next page.)
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binding site located in the first intron of the HNF4α gene
body during liver development41; however, in RLSCs, this
region was unable to recruit YAP (data not shown). Thus,
by MatInspector analysis we looked for other putative
TEAD binding sites on HNF4α promoter. A non-
canonical TEAD consensus site (5′-AAGCATGT-3′),
located at −518 from the transcription start site (TSS),
was found (Fig. 3a, upper panel).
Regarding Snail promoter, within 1500 bp upstream the
TSS we did not find any TEAD consensus motif, while we
identified a STAT3 binding site located at −350 from TSS
(Fig. 3a, lower panel). Since literature data demonstrated
the ability of YAP to physically interact and to cooperate
with STAT3 in the transcriptional activation in endo-
thelial cells42,43, we decided to analyze the YAP occupancy
of this region.
Fig. 2 YAP overexpression hampered HepE14 differentiation state. a RT-qPCR analysis for the indicated markers in HepE14 transiently
transfected with pQCXIH-Myc-YAP-5SA (HepE14 YAP5SA), compared with control cells transfected with empty vector (HepE14 CTR). The values are
calculated by the 2(−ΔCt) method, expressed as fold of expression versus the control (arbitrary value= 1) and shown as means ± S.E.M. of at least three
independent experiments. Statistically significant differences are reported (*p < 0.05; **p < 0.01). b Western blotting analysis for YAP, HNF4α and Snail
in HepE14 YAP5SA and HepE14 CTR. CDK4 was used as a loading control. c Immunofluorescence analysis of Snail and E-cadherin in HepE14 YAP5SA,
is compared with HepE14 CTR. Nuclei were stained with DAPI (blue). Images are representative of three independent experiments. Scale bar: 50 µm
(see figure on previous page)
Fig. 1 YAP silencing positively impacts on epithelial/hepatocyte differentiation. a RT-qPCR analysis for the indicated genes on RLSC and
HepE14 cell lines. b Immunofluorescence analysis for YAP (red) and the mesenchymal marker Vimentin (VIM, green) in RLSC and HepE14 cell lines.
Nuclei were stained with DAPI (blue). Images are representative of three independent cell cultures. Scale bar: 50 µm. c RT-qPCR analysis for the
indicated genes in YAP-silenced RLSCs (RLSC siYAP), compared with GFP-silenced control cells (RLSC siCTR). The values are calculated by the 2(−ΔCt)
method, expressed as fold of expression versus the control (arbitrary value= 1) and shown as means ± S.E.M. of five independent experiments.
Statistically significant differences are reported (*p < 0.05, ***p < 0.001; #p= 0.052; ns= not significant). d Western blot analysis for YAP, HNF4α and
Snail in RLSC siYAP and RLSCs siCTR. CDK4 was used as loading control. e RT-qPCR analysis for the indicated genes in YAP-silenced hepatocytes
(HepE14 siYAP), compared with control GFP-silenced cells. The values, calculated as in (c), are shown as means ± S.E.M. of at least five independent
experiments. Statistically significant differences are reported (**p < 0.01, ***p < 0.001). f Western blot analysis for YAP, HNF4α and Snail in
HepE14 siYAP and HepE14 siCTR. CDK4 was used as a loading control. g Immunofluorescence analysis of E-cadherin (ECAD, red) in HepE14 siYAP,
compared with HepE14 siCTR. Nuclei were stained with DAPI (blue). Images are representative of three independent experiments. Scale bar: 50 µm
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As shown in Fig. 3b, a chromatin immunoprecipitation
(ChIP) assay in HepE14 cells overexpressing YAP5SA
protein, unveiled a significant recruitment of YAP to the
chromatin region surrounding STAT3 binding site of
Snail promoter and to the non-canonical TEAD con-
sensus of HNF4α promoter. We used CTGF and RPL30
promoters as positive and negative controls of YAP
recruitment, respectively. Moreover, and in accordance
with the transcriptional upregulation of Snail and down-
regulation of HNF4α by YAP shown above, we observed
coherent variations of the corresponding chromatin
modifications. In particular, the acetylation of the histone
H3 (H3Ac), an activating chromatin modification, around
STAT3 consensus on Snail promoter was significantly
higher in HepE14 cells overexpressing YAP compared
with control cells. On the contrary, the acetylation of
HNF4α promoter resulted significantly lower (Fig. 3c, left
panel). Accordingly, the main repressive chromatin
modification, the trimethylation of lysine 27 of histone H3
(H3K27me3) on HNF4α promoter was significantly
increased by the YAP binding, while the same modifica-
tion on Snail promoter appeared reduced (Fig. 3c, right
panel). CTGF promoter was used as control of YAP-
dependent chromatin modifications.
Overall, the finding of the recruitment of YAP on Snail
and HNF4α promoters, and the observed coherent chro-
matin modifications, confirmed the involvement of YAP
in the transcriptional regulation of HNF4α and unveiled
Snail as a new transcriptional target of YAP.
We also identified a new binding site of TEAD/YAP on
HNF4α promoter, and more importantly, a site of YAP
recruitment on Snail promoter, including a STAT3
Fig. 3 YAP directly regulates Snail and HNF4α transcription. a Schematic representation of murine HNF4α P1 and Snail promoters. The amplified
regions are indicated by arrows. b qPCR analysis of ChIP assays with α-YAP antibody, and as control, with normal rabbit IgG on chromatin from
HepE14 CTR or HepE14 YAP5SA. TEAD consensus binding site on the murine CTGF promoter was used as positive control. RPL30 promoter is used as
negative control. Values derived from at least three independent experiments are calculated as IP/IgG and reported as means ± S.E.M. Statistically
significant differences are reported (*p < 0.05; ns= not significant). c qPCR analysis of ChIP assays with α- acetyl H3 antibody (acH3), α-H3K27me3
antibody, and as control, with normal rabbit IgG on the same chromatin shown in (b). Values derived from at least three independent experiments
are calculated as IP/IgG and reported as means ± S.E.M. respect to the control sample (arbitrary value= 1). The TEAD consensus site on the promoter
of the YAP positive target gene CTGF was used as control of YAP-dependent chromatin modifications. Statistically significant differences are reported
(*p < 0.05)
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consensus. To enforce the significance of this last obser-
vation, we investigated on the possible crosstalk between
STAT3 and YAP in liver cells and found that (i) STAT3
protein, expressed both in RLSCs and HepE14 cells, shows
a nuclear localization only in progenitor cells; (ii) STAT3
and YAP are able to physically interact; (iii) STAT3 is
recruited on Snail promoter in YAP-overexpressing
hepatocytes (Supplementary Fig. S2). Starting from this
data, we propose a new molecular cooperation of YAP and
STAT3 in controlling gene expression of liver cells, which
deserves further investigation.
YAP is positively regulated by Snail at post-translational
level
In our cell models, a reciprocal transcriptional control
between HNF4α and Snail regulating EMT/MET dynam-
ics and differentiation states was previously reported24.
The experiments of YAP manipulation shown above
demonstrated a positive and negative control of YAP on
Snail and HNF4α transcription, respectively, suggesting
that YAP could represent a further element of this epi-
static circuitry. To further characterize this molecular
interplay and the involvement of YAP in the circuitry, we
firstly explored the capability of Snail to control, in turn,
YAP expression. Literature data has shown functional
cooperation between Snail and YAP44,45; however, nothing
is known about their mutual control. After demonstrating
a transcriptional regulation of YAP on Snail (data above)
we have therefore set up experiments aimed at verifying
the reciprocal control.
While the expression of an ectopic Snail in HepE14
cells induced only a slight up-modulation of YAP tran-
scription (Fig. 4a), a massive increase of YAP protein,
mainly located in the nucleus and active on its target gene
Cyr61, has been observed (Fig. 4a, b, d). Notably, Snail
and YAP physical interaction has been shown (Fig. 4c),
Fig. 4 Snail positively controls YAP protein level and activity. a RT-qPCR analysis for YAP and its target gene CTGF in HepE14 infected with
pLPCX/Snail (HepE14 Snail) or pLPCX (HepE14 CTR). The values are calculated by the 2(−ΔCt) method, expressed as fold of expression versus
the control (arbitrary value= 1) and shown as means ± S.E.M. of three independent experiments. Statistically significant differences are reported:
**p < 0.01; ns= not significant). b Western blotting analysis for YAP and Snail in protein extracts from Snail-overexpressing HepE14 cells (SNAIL),
compared with control cells (CTR). CDK4 was used as a loading control. c Co-immunoprecipitation of YAP and Snail in RLSCs. Cells were lysed,
immunoprecipitated with anti-YAP antibody and then analyzed for Western Blotting with the indicated antibodies. As control, the
immunoprecipitation with normal rabbit antiserum (IgG) was performed. d Immunofluorescence analysis of YAP (red) in HepE14 Snail, compared
with HepE14 CTR. Nuclei were stained with DAPI (blue). Images are representative of three independent experiments. Scale bar: 50 µm
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that conceivably can play a role in the Snail-induced
stabilization/nuclear translocation of YAP.
YAP expression is steadily downregulated by HNF4α in
hepatocytes
About HNF4α, while previous data reported its ability to
interfere with YAP activity by competition with TEAD
proteins on YAP target gene promoters46, a HNF4α-
induced YAP gene regulation was not previously described.
To analyze the possible role of HNF4α on the regulation
of YAP gene expression, we performed experiments of
HNF4α silencing in HepE14 cells that demonstrated an
inverse correlation between HNF4α and YAP at tran-
scriptional and protein level (Fig. 5a, b, left panels).
Similar results have been obtained also in another cell
type, SW620 colon cell line, in which we recently
demonstrated a role of HNF4α in EMT/MET dynamics47
(Fig. 5a, b, right panels).
In extending our observations to an in vivo model, we
exploited liver samples from hepatocyte-specific HNF4α
knockout (KO) mice48. In this model, the loss of HNF4α
has been obtained in adult healthy mice through use of the
tamoxifen-inducible ErT2cre coupled to the serum albu-
min gene promoter. Also in this case, the loss of HNF4α
correlated with a significant upregulation of YAP tran-
scription (Fig. 5c). In this frame, it is worth recalling that
livers from the acute HNF4α knockout mice were pre-
viously shown to exhibit hepatocyte dedifferentiation
together with a marked induction of mesenchymal mar-
kers, highlighting the requirement of HNF4α in main-
taining the hepatocyte identity by means a stable
repression of the mesenchymal program23.
To investigate the direct involvement of HNF4α in the
control of YAP transcription we analyzed the occupancy
of YAP promoter. The in silico analysis of YAP promoter
by Genomatix MatInspector revealed a putative HNF4α
binding site located at −290 from TSS. ChIP assay per-
formed in HepE14 hepatocytes revealed a significant
recruitment of HNF4α to the corresponding chromatin
fragment (Fig. 5d), and coherently with transcriptional
results, a significant enrichment of the repressive histone
modification H3K27me3 on HNF4α binding site of YAP
promoter. Notably, the level of H3K27me3 on YAP pro-
moter is comparable to that of the Neurogenin 1 gene
promoter, here used as positive control (Fig. 5e).
Overall, our findings point to YAP as a new negative
target gene of HNF4α, enforcing the notion that the stable
repression of the mesenchymal program is required for
the maintenance of epithelial phenotype of liver cells.
Discussion
In this work, we demonstrated the functional role of
YAP in the negative control of hepatocyte differentiation
and unveiled the molecular mechanisms involved. We
showed that the dynamic modulation of YAP expression
(overexpression vs silencing) impacts on the induction/
maintenance of the epithelial/hepatocyte identity con-
trolling the expression of the MET/hepatocyte master
gene HNF4α and of the EMT/stemness master gene Snail.
The functional interactions between YAP and HNF4α
have been previously reported. Hippo signaling influences
the redistribution of liver-specific transcriptional factors
(including HNF4α and FoxA1) on a wide range of reg-
ulatory sequences16, affecting liver cell differentiation fate;
moreover, a direct binding of YAP to an intronic reg-
ulatory sequence of HNF4α gene can be observed in liver
cells from LATS1/2 knockout mice41. On the other side,
HNF4α is able to negatively control YAP activity in liver
cancer cells by competing with YAP for TEAD4 binding46.
In accord with and in addition to these observations, we
demonstrated that the functional link between YAP and
HNF4α is also based on a reciprocal transcriptional
inhibition through the direct occupancy of their own
promoters.
Of note, we identified a new binding site for YAP/TEAD
in the HNF4α promoter P1, different from the previously
characterized site included in the first intron of the gene41.
Furthermore, we showed for the first time a HNF4α steady-
state binding and an inhibitory activity on YAP promoter in
hepatocytes. We demonstrated that in hepatocytes HNF4α
directly downregulates the expression of YAP gene, thus
contributing to the repression of YAP-dependent
mesenchymal program. Moreover, the observation of
YAP upregulation in the in vivo model of HNF4α knockout
mice strengthened the biological importance of the data
obtained in cell lines. These findings reinforce the evidence
that HNF4α, other than to activate and to maintain the
epithelial/hepatocyte-specific program, actively and stably
represses the mesenchymal one, downregulating Snail23 as
well as YAP gene transcription to allow the fully expression
of the differentiated phenotype.
A novelty of our work is also the identification of a
reciprocal regulation between YAP and SNAIL. Previous
reports suggested a functional cooperation between these
proteins. Snail/Slug-YAP/TAZ complexes have been
described in mesenchymal stem cells and during bone
formation44,45. Furthermore, YAP was shown to cooperate
with EMT master factor ZEB1 in the activation of the
ZEB1-dependent cancer-promoting gene expression49.
Moreover, an upregulation of Snail and YAP during
TGFβ-induced EMT was previously described31,50–52.
Here, we identified Snail as new transcriptional target gene
of YAP. Indeed, by ChIP assays, we demonstrated Snail
promoter occupancy by YAP, associated with a significant
increase of the activating chromatin modification, the H3
histone acetylation. Our data is in accord with a previous
report showing the transcriptional regulation by YAP of
another member of Snail family, Snai2/Slug53.
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Fig. 5 HNF4α negatively controls YAP expression and activity. a RT-qPCR analysis for the indicated genes in HNF4α-silenced HepE14
(HepE14 siHNF4) and colon SW620 cells (SW620 siHNF4), compared with GFP-silenced control cells. The values are calculated by the 2(−ΔCt) method,
expressed as fold of expression versus the control (arbitrary value= 1) and shown as means ± S.E.M. of at least three independent experiments.
Statistically significant differences are reported (*p < 0.05; **p < 0.01). b Western blotting analysis for YAP and HNF4α in HNF4α-silenced HepE14 and
SW620 cells (siHNF4), compared with GFP-silenced control cells (siCTR). GAPDH was used as a loading control. c RT-qPCR analysis of YAP and HNF4α
in liver samples from four hepatocyte-specific HNF4α knockout (KO) mice48 and four wild-type (WT) mice. Statistically significant differences between
the two groups of mice are reported (*p < 0.05). d qPCR analysis of ChIP assays with α-HNF4α antibody (HNF4), and as control, with normal rabbit IgG
on chromatin from HepE14 cells. Values derived from at least four independent experiments are calculated as IP/IgG and reported as means ± S.E.M.
respect to the IgG sample (arbitrary value= 1). RPL30 promoter was used as negative control (***p < 0.001; ns= not significant). e qPCR analysis of
ChIP assays with α-H3K27me3 antibody (H3K27me3), and as control, with normal rabbit IgG on the chromatin from HepE14 cells. Values derived from
at least three independent experiments are calculated as IP/IgG and reported as means ± S.E.M. respect to the IgG sample (arbitrary value= 1). RPL30
and Neurogenin promoters were used as negative and positive control, respectively (*p < 0.05; ns= not significant)
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In silico study of the Snail promoter region recruiting
YAP did not reveal a consensus for TEAD while unveiled
a STAT3 putative binding site, suggesting the involve-
ment of this transcription factor in mediating the binding
of YAP to DNA. Data from ChIP assay performed in YAP-
overexpressing hepatocytes confirmed the recruitment of
both STAT3 and YAP on Snail promoter. Further studies
will be needed to define the role of STAT3 in the YAP-
dependent transcriptional regulation in hepatocytes.
Importantly, we herein also showed that Snail in turn
upregulates YAP at protein level and induces its nuclear
localization, through a mechanism in which the physi-
cal interaction between the two proteins could play
a role.
Overall, being HNF4α and Snail already described as
components of an epistatic mini-circuitry of reciprocal
repression, our results suggest that YAP could integrate
this circuit influencing different liver cell outcomes
(Fig. 6). This regulatory loop could be involved not only in
the physiological maintenance/induction of differentia-
tion states in liver cells but also, when dysregulated, in
pathological cellular processes.
In conclusion, the finding of this work demonstrated
that YAP is a new member of a molecular circuitry of
reciprocal control between master factors, responsible for
liver cell differentiation process. The demonstration that
YAP is able to integrate itself into a tissue-specific
molecular network shed new light on how transducers
of several general stimuli can control tissue-specific cell
outcomes.
Materials and methods
Cell lines and culture conditions
Resident liver stem cells (RLSCs) and hepatocytes E14
(HepE14) are immortalized and non-tumorigenic cell
lines derived from murine liver explants at 14th days of
development.
RLSCs are stem/precursor cells, displaying a typical
stemness gene expression profile, self-renewing capability
and multi-lineage differentiation potential both in culture
and in vivo35,36. RLSCs were maintained at 37 °C, in a
humidified atmosphere with 5% CO2 on collagen I (Col-
lagen I, Rat Tail; Gibco-Life Technologies) coated dishes
in Dulbecco’s modified Eagle’s medium (DMEM; Gibco-
Life Technologies), supplemented with 10% fetal bovine
serum (FBS), 2 mM glutamine (Gibco-Life Technologies)
and antibiotics.
HepE14 are hepatocytes displaying a differentiated
phenotype and a coherent gene expression profile. They
have been used in a variety of studies of hepatocyte
physiology being able to express a wide range of liver
functions and products34,54–58. HepE14 cells were grown
at 37 °C, in a humidified atmosphere with 5% CO2 on
collagen I (Collagen I, Rat Tail; Gibco-Life Technologies)
coated dishes in RPMI-1640 medium (Gibco-Life Tech-
nologies), supplemented with 10% FBS, 2 mM glutamine
(Gibco-Life Technologies), 50 ng/ml EGF, 30 ng/ml IGF II
(PeproTech), 10 µg/ml insulin (Roche) and antibiotics.
SW620 human colon-carcinoma cell line was grown in
DMEM supplemented with 10% FBS (GIBCO® Life
Technology, Monza, Italy) and antibiotics.
Cell transfections and retroviral infections
YAP-overexpressing HepE14 cells were obtained by
transient transfection with pQCXIH-Myc-YAP5SA (gift
from Kunliang Guan, Addgene plasmid # 33093)7 or the
empty vector, by Lipofectamine 2000 transfection reagent
(Invitrogen, Thermo Fisher) according to the manu-
facturer’s protocol. Cells were collected 48 h after trans-
fection. Notably, YAP5SA protein, carrying mutations of
LATS1/2-dependent phosphorylation sites (S61A,
S109A, S127A, S164A, S381A), results constitutively
active7.
Murine Snail and human HNF4α overexpressing cells
were obtained by retroviral infection as previously
described21. Snail recombinant retroviruses were pro-
duced in BOSC 23 packaging cells according to standard
procedures by transient transfection of the retroviral
construct pLPCX/Snail or pLPCX21. All viral particles
were collected 48 h after transfection.
Fig. 6 Suggested molecular circuitry controlling stemness/
differentiation in liver cells, based on the reciprocal regulation
among YAP, Snail, and HNF4α proteins. YAP protein has a direct
role of in the repression of hepatocyte differentiation through the
transcriptional upregulation of Snail and downregulation of HNF4α.
Snail and YAP cooperate in the active repression of epithelial/
hepatocyte differentiation through their reciprocal upregulation and
the HNF4α downregulation. HNF4α actively and stably represses the
mesenchymal program, downregulating both Snail and YAP. The
same molecular interplay could be involved in different physiological
and pathological cell outcomes
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RNA interference
Cells were transfected with equal amounts (100 pmol)
of ON-TARGET plus SMARTpool Mouse YAP1 siRNA
(22601; GE Healthcare Dharmacon, Lafayette, CO, USA),
ON-TARGET plus SMARTpool Human HNF4α siRNA
(GE Healthcare Dharmacon, Lafayette, CO, USA) or
siRNA against GFP (5′-GGUGGUGACGAUCUGGGC
UUUTT-3′) by Lipofectamine RNAiMAX (Invitrogen San
Diego, CA) according to the manufacturer’s protocol.
RNA and proteins were harvested and analyzed after 48 h.
RT-qPCR
Total RNAs were extracted with Total RNA Mini Kit
(Geneaid) according to manufacturer’s protocol and
reverse-transcribed using PrimeScripte RT Master Mix
(Perfect Real Time, Takara). cDNAs were amplified by
qPCR reaction with GoTaq qPCR Master Mix (Pro-
mega) in Bio-Rad-iQ-iCycler. Relative amounts, calcu-
lated with the 2(−ΔCt) method, were normalized
with respect to the housekeeping gene RPL34 (60S
ribosomal protein L34). The murine and human pri-
mers utilized are listed in Supplementary Tables 1
and 2, respectively.
SDS-PAGE and Western Blotting
Cells were lysed in RIPA buffer containing freshly added
cocktail protease inhibitors. Protein concentration was
determined with Protein Assay Dye Reagent (Bio-Rad).
Equal amounts of proteins were loaded on 12% acryla-
mide gels and then transferred to a nitrocellulose mem-
brane (Bio-Rad). Blots were probed with the following
primary antibodies: mouse monoclonal α-Snail (L70G2,
Cell Signaling; 1:1000); mouse monoclonal α-YAP (SC-
101199, Santa Cruz Biotechnology, inc.; 1:1000); goat
monoclonal α-HNF4α (SC-6556 Santa Cruz Biotechnol-
ogy, inc.; 1:1000); mouse monoclonal α-STAT3 (124H6,
Cell Signaling; 1:1000); rabbit monoclonal α-CDK4 (C22,
SC-260, Santa Cruz Biotechnology, inc.; 1:1000); mouse
monoclonal α-GAPDH (MAB374, Millipore, Merck;
1:1000). Blots were then incubated with HRP-conjugated
species-specific secondary antibodies (α-mouse IgG (H+
L)-HRP Conjugated or α-Rabbit IgG (H+ L)-HRP Con-
jugated from Bio-Rad; α-goat IgG (H+ L) (705-036-147)-
HRP Conjugated from Jackson immune Reasearch
Laboratories, USA), followed by enhanced chemilumi-
nescence reaction (WESTAR Nova 2.0 or WESTAR etaC,
Cyanagen).
Immunofluorescence analysis
For indirect immunofluorescence analysis, cells were
fixed in 4% paraformaldehyde, permeabilized with 0.2%
Triton-X100 and incubated with the following primary
antibodies: mouse monoclonal α-YAP (SC-101199,
Santa Cruz Biotechnology, inc.; 1:50); mouse monoclonal
α-Snail (L70G2, Cell Signaling Technology; 1:50); rabbit
monoclonal α-Vimentin (ab92547, Abcam, Cambridge,
UK; 1:400); mouse monoclonal α-E-cadherin (BD 610182,
BD Biosciences Pharmingen, Palo Alto, CA, USA; 1:50);
mouse monoclonal α-STAT3 (124H6, Cell Signaling;
1:50). Secondary antibodies: α-mouse Alexa-Fluor 594
and α-rabbit Alexa-Fluor 488 (Molecular Probes, Eugene,
OR, USA; 1:400). Nuclei were stained with DAPI (Cal-
biochem Merck, Darmstadt, Germany). Preparations were
examined under Nikon Eclipse fluorescent microscope
equipped with a CCD camera (Nikon Inc.). Digital images
were acquired by Nikon NIS elements software
(Nikon Corporation) and processed with Adobe Photo-
shop 7 software (Adobe Systems, Mountain View, CA).
The same enhanced color levels were applied for all
channels.
Chromatin Immunoprecipitation (ChIP)
ChIP assays were performed as previously reported21 by
using 5 µg rabbit α-YAP (H-125X, Santa Cruz Bio-
technology Inc.), rabbit α-HNF4Α (H-171X, Santa Cruz
Biotechnology), mouse α-STAT3 (124H6, Cell Signaling)
or the negative control rabbit IgG (Millipore Corp., Bed-
ford, MA, USA). Equal amounts of immunoprecipitated
DNA and relative controls were used for qPCR analysis
with the following primers: HNF4α promoter, forward 5′-
CGGTTCCCAAAGCATGTGAC-3′ and reverse 5′-ATA
AAGCTGTCCTGGGTCGC-3′; Snail promoter, 5′-TGT
TCAGGGCTGTGTAGAC-3′ and reverse 5′-GAGCTG
CTGACCTTTGG-3′; YAP promoter, forward 5′-ACCT
TAGTGCGGGTGAACAG-3′ and reverse 5′-GTCGCTA
CATTCCTGCAGAC-3′, CTGF promoter, forward 5′-CA
ATCCGGTGTGAGTTGATG-3′ and reverse 5′-GGCG
CTGGCTTTTATACG-3′, RPL30 promoter, forward
5′-TAAGGCAGGAAGATGGTGG-3′ and reverse 5′-CA
GTGTGCTCAAATCTATCC-3′; Neurogenin 1, forward
5′-CCTCCCGCGAGCATAAATTA-3′ and reverse
5′- GCGATCAGATCAGCTCCTGT-3′. qPCR analysis of
immunoprecipitated samples (IP) and of negative control
(IgG) were normalized to total chromatin input and
expressed as (IP/IgG)/Input.
For the analysis of histone modifications (Histone
ChIP), chromatins were immunoprecipitated with 5 μg of
Anti-trimethyl-Histone H3 (Lys27) (07-449; Millipore
Corp., Bedford, MA, USA), or Anti-acetyl-Histone H3
Antibody (06-599; Millipore Corp., Bedford, MA, USA) or
rabbit IgG (Millipore Corp., Bedford, MA, USA) by using
Magna ChIP protein A magnetic beads (Millipore). The
immunoprecipitated DNA was amplified by qPCR. Data
were expressed as (IP/IgG)/Input and normalized respect
to the immunoprecipitation efficiency, evaluated through
the qPCR of the promoter of the housekeeping gene
RPL30 (acetylation) or the promoter of Neurogenin 1, a
gene not expressed in the liver (trimethylation).
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Statistical analysis
Paired one-tailed t-test and Excel function were used for
statistical analyses of at least three independent experi-
mental replicates. The Mann–Whitney U test was used to
compare differences between the two groups of mice
(knockout vs wild type). P-values (p) < 0.05 were con-
sidered statistically significant (*p < 0.05; **p < 0.01; ***p <
0.001).
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